{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:45:18Z","timestamp":1794861918159,"version":"4.9.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.amepre.2025.107742","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:28:04Z","timestamp":1749497284000},"page":"107742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trends in Nonfatal Fentanyl Exposures Involving Stimulants in the United States, 2015\u20132023"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-5874","authenticated-orcid":false,"given":"Nicole D.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7329-2740","authenticated-orcid":false,"given":"Joshua C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-8536","authenticated-orcid":false,"given":"Linda B.","family":"Cottler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3059-9993","authenticated-orcid":false,"given":"Silvia S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-9415","authenticated-orcid":false,"given":"Joseph J.","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2025.107742_bib0001","series-title":"Drug Overdose Deaths in the United States, 2003\u20132023. NCHS Data Brief, no 522","author":"Garnett","year":"2024"},{"issue":"4","key":"10.1016\/j.amepre.2025.107742_bib0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"12","key":"10.1016\/j.amepre.2025.107742_bib0003","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021","volume":"118","author":"Friedman","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.amepre.2025.107742_bib0004","series-title":"Co-Involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011\u20132021. NCHS Data Brief, no 474","author":"Spencer","year":"2023"},{"issue":"50","key":"10.1016\/j.amepre.2025.107742_bib0005","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends and characteristics of drug overdose deaths involving illicitly manufactured fentanyls \u2014 United States, 2019\u20132020","volume":"70","author":"O\u2019Donnell","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.amepre.2025.107742_bib0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms","volume":"42","author":"Jones","year":"2020","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.amepre.2025.107742_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108286","article-title":"Introducing NIDA\u2019s new National Drug Early Warning System","volume":"217","author":"Cottler","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.amepre.2025.107742_bib0008","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jaac.2012.11.014","article-title":"Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(\u00ae)) System","volume":"52","author":"Zosel","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.amepre.2025.107742_bib0009","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/15563650.2020.1834219","article-title":"2019 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 37th Annual Report","volume":"58","author":"Gummin","year":"2020","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.amepre.2025.107742_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14688","article-title":"Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction","volume":"1508","author":"Jones","year":"2022","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.amepre.2025.107742_bib0011","series-title":"National Drug Threat Assessment 2024","year":"2024"},{"issue":"1","key":"10.1016\/j.amepre.2025.107742_bib0012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2005.07.012","article-title":"Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects","volume":"82","author":"Newton","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.amepre.2025.107742_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103463","article-title":"Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks","volume":"99","author":"Daniulaityte","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2025.107742_bib0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s13181-022-00924-0","article-title":"Characterization of nonfatal opioid, cocaine, methamphetamine, and polydrug exposures and clinical presentations reported to the Toxicology Investigators Consortium Core Registry, January 2010\u2013December 2021","volume":"19","author":"Glidden","year":"2023","journal-title":"J Med Toxicol"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074937972500234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074937972500234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:10:57Z","timestamp":1765541457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074937972500234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S074937972500234X"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2025.107742","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Nonfatal Fentanyl Exposures Involving Stimulants in the United States, 2015\u20132023","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2025.107742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107742"}}